[1] La T, F B, Rl S, J F, J L, A J, Cancer Constitutes An Enormous Burden On Society In More And Less Economically Developed Countries Alike. The Occurrence Of Cancer Is Increasing Because Of The Growth And Aging Of The Population A W A A, Breast Cancer Remains The Leading Cause Of Cancer Death Among Females In Less Developed Countries. Other Leading Causes Of Cancer Death In More Developed Countries Include Colorectal Cancer Among Males And Females And Prostate Cancer Among Males. In Less Developed Countries L A S C. CA: a cancer journal for clinicians, 2015, 65(2):87-108.
[2] Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 2019; 8: e191–203.
[3] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi:10.3322/ caac.21492
[4] Lemp Julia M,De Neve Jan-Walter,Bussmann Hermann et al. Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries.[J] .JAMA, 2020, 324: 1532-1542.
[5] Chen W, Sun K, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res 2018;30(1):1-12
[6] Benedet JL, Bender H, Jones H III, et al: FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers: FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70:209-262, 2000
[7] International Federation of Gynecology and Obstetrics: 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95:S1-257, 2006 (suppl 1)
[8]Monk Bradley J,Tewari Krishnansu S,Koh Wui-Jin,Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions.[J] .J Clin Oncol, 2007, 25: 2952-65.
[9]Petignat Patrick,Loubeyre Pierre,Should we modify the current FIGO staging system for early-stage cervical cancer?[J] .Expert Rev Anticancer Ther, 2008, 8: 1015-7.
[10]Ackermann Sven,Beckmann Matthias W,Accuracy of cervical cancer staging needs improvement.[J] .Am J Obstet Gynecol, 2005, 192: 659; author reply 660.
[11] Lian Lijuan. Lin Qiaozhi Gynecological Oncology[M]. 3rd edition. Beijing: People's Medical Publishing House, 2000.311-314.
[12] Ruirui Sun, Niyazi Huerxidan, Huarong Zhao, Lei Zhang, Yiming Reheman, Yongxing Bao ). Journal of Clinical Oncology, 2015, (8):704-708.
[13] Xiao-Lei Zhang, Juan Peng, Jian-Hua Zheng. International Journal of Reproductive Health/Family Planning, 2011, 30(2):153-154.
[14] Wang Tong (Tong Wang), Wu Yumei (Yumei WU). China Medical Herald, 2017, 14(24):46-49.5 Analysis of the difference between FIGO staging and surgical pathological staging of early cervical cancer. Chinese modern doctors August 2017 Volume 55 Number 22
[15] Shrivastava S, Mahantshetty U, Engineer R, Tongaonkar H, Kulkarni J, Dinshaw K. Treatment and outcome in cancer cervix patients treated between 1979 and 1994: a single institutional experience.J Cancer Res Ther. 2013;9(4):672-679.
[16] Shrivastava Shyamkishore,Mahantshetty Umesh,Engineer Reena et al. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.[J] .JAMA Oncol, 2018, 4: 506-513.
[17] Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet 2019; 393: 169–82
[18] Höckel Michael,Wolf Benjamin,Schmidt Katja et al. Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study.[J] .Lancet Oncol, 2019, 20: 1316-1326.